Immediate Impact
2 by Nobel laureates 68 standout
Citing Papers
EASL Clinical Practice Guidelines on the management of hepatocellular carcinoma
2024 Standout
Global epidemiology of cirrhosis — aetiology, trends and predictions
2023 Standout
Works of Christoph Markert being referenced
First-in-human application of the novel hepatitis B and hepatitis D virus entry inhibitor myrcludex B
2016
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Christoph Markert | 132 | 65 | 67 | 164 | 124 | 15 | 438 | |
| J.P. Benhamou | 146 | 54 | 43 | 124 | 95 | 16 | 424 | |
| L Verbist | 177 | 122 | 41 | 106 | 91 | 13 | 455 | |
| M. Schmid | 144 | 43 | 63 | 88 | 134 | 23 | 508 | |
| Pedro Martínez-Odriozola | 208 | 34 | 42 | 209 | 188 | 8 | 457 | |
| Mariano Madurga | 264 | 69 | 51 | 91 | 68 | 12 | 511 | |
| Cheryl Chairez | 114 | 31 | 23 | 146 | 89 | 19 | 509 | |
| Alma L. Maldonado | 156 | 46 | 86 | 73 | 40 | 15 | 434 | |
| Miguel Jiménez‐Pérez | 259 | 28 | 28 | 153 | 99 | 7 | 414 | |
| Nilay Thakkar | 45 | 52 | 67 | 73 | 44 | 17 | 453 | |
| Anuj Walia | 128 | 24 | 18 | 179 | 53 | 14 | 503 |
All Works
Loading papers...